http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020523328-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
filingDate 2018-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2020523328-A
titleOfInvention Syk inhibitor and method of using the same
abstract Provided are Syk inhibitors and methods of use thereof. Specifically, the present invention provides a quinolinone represented by formula (I), a quinazolinone derivative, or a pharmaceutically acceptable salt thereof, a method for producing the same, a pharmaceutical composition, and use thereof in a therapeutic agent for a Syk receptor-related disease. [Chemical 1]
priorityDate 2017-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010053757-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2450746-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017001733-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017501215-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006519846-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013522238-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011510990-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015091815-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146479550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID142494321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418401052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412175117

Total number of triples: 45.